Status:
COMPLETED
Diagnostic Performance of Urinary Gluten Immunogenic Peptides in Monitoring the Adherence to Gluten-free Diet.
Lead Sponsor:
Università Politecnica delle Marche
Conditions:
Celiac Disease
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
The purpose of the GRRES study is to assess the clinical usefulness of urinary gluten immunogenic peptides test as a marker of gluten-free diet adherence using the rapid immunochromatographic assay ba...
Detailed Description
A strict and permanent gluten free diet (GFD) is the only effective treatment resulting in full clinical, serological and histological remission, avoiding long-term complications in celiac disease (CD...
Eligibility Criteria
Inclusion
- healthy volunteers
- 20-40 years old
- written informed consent
Exclusion
- type 1 diabetes
- chronic or acute inflammatory diseases of the gastrointestinal tract (CD, non-celiac gluten sensitivity, Crohn's disease, ulcerative colitis, food allergy, acute gastroenteritis ≤ 4 weeks prior to the study start)
- pregnancy or lactation
- chronic intake of medications and supplements
- refusal/withdrawal of written informed consent.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04477239
Start Date
October 1 2020
End Date
December 31 2020
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Department of Pediatrics
Ancona, Italy, 60123